Sativex® and clinical–neurophysiological measures of spasticity in progressive multiple sclerosis-Reference-Cited by-同舟云学术

Sativex® and clinical–neurophysiological measures of spasticity in progressive multiple sclerosis

Published:2015-08-20 Issue:11 Volume:262 Page:2520-2527
ISSN:0340-5354
Container-title:Journal of Neurology
language:en
Short-container-title:J Neurol

Author:

Leocani Letizia,Nuara Arturo,Houdayer Elise,Schiavetti Irene,Del Carro Ubaldo,Amadio Stefano,Straffi Laura,Rossi Paolo,Martinelli Vittorio,Vila Carlos,Sormani Maria Pia,Comi Giancarlo

Publisher

Springer Science and Business Media LLC

Subject

Neurology (clinical),Neurology

Link

http://link.springer.com/content/pdf/10.1007/s00415-015-7878-1.pdf

Reference39 articles.

1. Compston A, Coles A (2002) Multiple sclerosis. Lancet 359:1221–1231

2. Richards RG, Sampson FC, Beard SM, Tappenden P (2002) A review of the natural history and epidemiology of multiple sclerosis: implications for resource allocation and health economic models. Health Technol Assess 6:1–73

3. Zajicek J, Fox P, Sanders H, Wright D, Vickery J, Nunn A, Thompson A, UK MS Research Group (2003) Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial. Lancet 362:1517–1526

4. Baker D, Pryce G (2003) The therapeutic potential of cannabis in multiple sclerosis. Expert Opin Investig Drugs 12:561–567

5. Di Marzo V (2007) The endocannabinoid system for the development of new drugs for spasticity. Drugs Fut 32:341–351

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cannabiskonsum und Cannabiskonsumstörungen;Der Nervenarzt;2024-08-12

2. The Therapeutic Potential and Molecular Mechanisms Underlying the Neuroprotective Effects of Sativex^® - A Cannabis-derived Spray;Mini-Reviews in Medicinal Chemistry;2024-08

3. Trends in prescription and cost of Sativex, a cannabinoid-based medicine, in treating patients with multiple sclerosis in England;Journal of Pharmaceutical Policy and Practice;2024-05-08

4. Nabiximols is Efficient as Add-On Treatment for Patients with Multiple Sclerosis Spasticity Refractory to Standard Treatment: A Systematic Review and Meta-Analysis of Randomised Clinical Trials;Current Neuropharmacology;2023-12

5. What's your cup of tea? The role of herbal compounds in the management of multiple sclerosis;Multiple Sclerosis and Related Disorders;2023-08